Company · CIK 0001863127 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Tyra Biosciences, Inc. · TYRA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 AForm 4 → | Sep 17, 7:29 pm EDT | Todd HarrisPresident and CEO, Director | 864 | $9.13 | $7,887 | 1,438,495 | — | |
| Sep 15, 2026 AForm 4 → | Sep 17, 7:26 pm EDT | Yuliya RuebVice President, Finance (PAO) | 2,925 | $9.13 | $26,702 | 11,258 | — | |
| Sep 15, 2026 AForm 4 → | Sep 17, 7:25 pm EDT | Alan FuhrmanChief Financial Officer | 951 | $9.13 | $8,682 | 37,115 | — | |
| Sep 9, 2026 PForm 4 → | Sep 11, 4:30 pm EDT | Rehan VerjeeDirector | 972 | $20.58 | $20,000 | 972 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 PForm 4 → | Sep 17, 4:31 pm EDT | RA CAPITAL MANAGEMENT, L.P. +4Director, 10% Owner | 9,078,529 | $22.03 | $199,990,915 | 11,616,986 | — |